Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Apr. 30, 2020 | Jun. 01, 2020 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Apr. 30, 2020 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 | |
Trading Symbol | AMBA | |
Entity Registrant Name | AMBARELLA, INC. | |
Entity Central Index Key | 0001280263 | |
Current Fiscal Year End Date | --01-31 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Current Reporting Status | Yes | |
Entity Common Stock, Shares Outstanding | 34,346,866 | |
Entity File Number | 001-35667 | |
Entity Tax Identification Number | 98-0459628 | |
Entity Address, Address Line One | 3101 Jay Street | |
Entity Address, City or Town | Santa Clara | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 95054 | |
City Area Code | 408 | |
Local Phone Number | 734-8888 | |
Entity Incorporation, State or Country Code | E9 | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Title of 12(b) Security | Ordinary Shares, $0.00045 Par Value Per Share | |
Security Exchange Name | NASDAQ | |
Entity Interactive Data Current | Yes |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Current assets: | ||
Cash and cash equivalents | $ 236,585 | $ 231,403 |
Marketable debt securities | 174,742 | 173,345 |
Accounts receivable, net | 20,684 | 18,487 |
Inventories | 21,957 | 22,971 |
Restricted cash | 9 | 9 |
Prepaid expenses and other current assets | 4,789 | 4,975 |
Total current assets | 458,766 | 451,190 |
Property and equipment, net | 5,401 | 5,614 |
Deferred tax assets, non-current | 9,943 | 10,400 |
Intangible assets, net | 16,391 | 17,826 |
Operating lease right-of-use assets, net | 9,272 | 9,935 |
Goodwill | 26,601 | 26,601 |
Other non-current assets | 5,359 | 5,710 |
Total assets | 531,733 | 527,276 |
Current liabilities: | ||
Accounts payable | 20,589 | 14,910 |
Accrued and other current liabilities | 27,262 | 34,970 |
Operating lease liabilities, current | 2,101 | 2,181 |
Income taxes payable | 749 | 691 |
Deferred revenue, current | 802 | 701 |
Total current liabilities | 51,503 | 53,453 |
Operating lease liabilities, non-current | 7,386 | 7,975 |
Other long-term liabilities | 17,261 | 17,776 |
Total liabilities | 76,150 | 79,204 |
Commitments and contingencies (Note 13) | 0 | 0 |
Shareholders' equity: | ||
Preference shares, $0.00045 par value per share, 20,000,000 shares authorized and no shares issued and outstanding at April 30, 2020 and January 31, 2020, respectively | 0 | 0 |
Ordinary shares, $0.00045 par value per share, 200,000,000 shares authorized at April 30, 2020 and January 31, 2020, respectively; 34,342,097 shares issued and outstanding at April 30, 2020; 33,805,609 shares issued and outstanding at January 31, 2020 | 15 | 15 |
Additional paid-in capital | 284,557 | 261,220 |
Accumulated other comprehensive income | 405 | 768 |
Retained earnings | 170,606 | 186,069 |
Total shareholders’ equity | 455,583 | 448,072 |
Total liabilities and shareholders' equity | $ 531,733 | $ 527,276 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Apr. 30, 2020 | Jan. 31, 2020 |
Statement Of Financial Position [Abstract] | ||
Preference shares, par value | $ 0.00045 | $ 0.00045 |
Preference shares, shares authorized | 20,000,000 | 20,000,000 |
Preference shares, shares issued | 0 | 0 |
Preference shares, shares outstanding | 0 | 0 |
Ordinary shares, par value | $ 0.00045 | $ 0.00045 |
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares, shares issued | 34,342,097 | 33,805,609 |
Ordinary shares, shares outstanding | 34,342,097 | 33,805,609 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Income Statement [Abstract] | ||
Revenue | $ 54,645 | $ 47,188 |
Cost of revenue | 22,625 | 19,335 |
Gross profit | 32,020 | 27,853 |
Operating expenses: | ||
Research and development | 34,200 | 33,017 |
Selling, general and administrative | 13,435 | 13,077 |
Total operating expenses | 47,635 | 46,094 |
Loss from operations | (15,615) | (18,241) |
Other income, net | 1,278 | 2,196 |
Loss before income taxes | (14,337) | (16,045) |
Provision for income taxes | 1,126 | 1,266 |
Net loss | $ (15,463) | $ (17,311) |
Net loss per share attributable to ordinary shareholders: | ||
Basic | $ (0.45) | $ (0.53) |
Diluted | $ (0.45) | $ (0.53) |
Weighted-average shares used to compute net loss per share attributable to ordinary shareholders: | ||
Basic | 34,080,330 | 32,492,044 |
Diluted | 34,080,330 | 32,492,044 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Statement Of Income And Comprehensive Income [Abstract] | ||
Net loss | $ (15,463) | $ (17,311) |
Other comprehensive income (loss), net of tax: | ||
Unrealized gains (losses) on investments | (363) | 254 |
Other comprehensive income (loss), net of tax | (363) | 254 |
Comprehensive loss | $ (15,826) | $ (17,057) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands | Total | Outstanding Ordinary Shares [Member] | Additional Paid-in Capital [Member] | Accumulated Other Comprehensive Income [Member] | Retained Earnings [Member] |
Beginning Balance, Amount at Jan. 31, 2019 | $ 419,489 | $ 15 | $ 188,516 | $ 97 | $ 230,861 |
Beginning Balance, Shares at Jan. 31, 2019 | 32,303,540 | ||||
Issuance of shares through employee equity incentive plan, Amount | 1,520 | $ 0 | 1,520 | 0 | 0 |
Issuance of shares through employee equity incentive plan, Shares | 335,301 | ||||
Issuance of shares through employee stock purchase plan, Amount | 3,063 | $ 0 | 3,063 | 0 | 0 |
Issuance of shares through employee stock purchase plan, Shares | 99,759 | ||||
Stock-based compensation expense related to stock awards granted to employees and consultants | 15,423 | $ 0 | 15,423 | 0 | 0 |
Net unrealized gains (losses) on investments - net of taxes | 254 | 0 | 0 | 254 | 0 |
Net loss | (17,311) | 0 | 0 | 0 | (17,311) |
Ending Balance, Amount at Apr. 30, 2019 | 422,438 | $ 15 | 208,522 | 351 | 213,550 |
Ending Balance, Shares at Apr. 30, 2019 | 32,738,600 | ||||
Beginning Balance, Amount at Jan. 31, 2020 | $ 448,072 | $ 15 | 261,220 | 768 | 186,069 |
Beginning Balance, Shares at Jan. 31, 2020 | 33,805,609 | 33,805,609 | |||
Issuance of shares through employee equity incentive plan, Amount | $ 6,463 | $ 0 | 6,463 | 0 | 0 |
Issuance of shares through employee equity incentive plan, Shares | 478,643 | ||||
Issuance of shares through employee stock purchase plan, Amount | 2,660 | $ 0 | 2,660 | 0 | 0 |
Issuance of shares through employee stock purchase plan, Shares | 83,564 | ||||
Stock repurchase, Amount | (1,000) | $ 0 | (1,000) | 0 | 0 |
Stock repurchase, Shares | (25,719) | ||||
Stock-based compensation expense related to stock awards granted to employees and consultants | 15,214 | $ 0 | 15,214 | 0 | 0 |
Net unrealized gains (losses) on investments - net of taxes | (363) | 0 | 0 | (363) | 0 |
Net loss | (15,463) | 0 | 0 | 0 | (15,463) |
Ending Balance, Amount at Apr. 30, 2020 | $ 455,583 | $ 15 | $ 284,557 | $ 405 | $ 170,606 |
Ending Balance, Shares at Apr. 30, 2020 | 34,342,097 | 34,342,097 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Cash flows from operating activities: | ||
Net loss | $ (15,463) | $ (17,311) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 2,872 | 2,708 |
Amortization/accretion of marketable debt securities | 10 | (378) |
Stock-based compensation | 16,036 | 16,460 |
Deferred income taxes | 457 | 21 |
Other non-cash items, net | (38) | 142 |
Changes in operating assets and liabilities: | ||
Accounts receivable | (2,197) | (245) |
Inventories | 1,014 | 617 |
Prepaid expenses and other current assets | 193 | 1,007 |
Other assets | 351 | 60 |
Accounts payable | 5,679 | 3,254 |
Accrued liabilities | (1,343) | (454) |
Income taxes payable | 58 | (311) |
Deferred revenue | 101 | 36 |
Lease Liabilities | (689) | (727) |
Other long-term liabilities | 598 | 453 |
Net cash provided by operating activities | 7,639 | 5,332 |
Cash flows from investing activities: | ||
Purchase of investments | (49,077) | (35,583) |
Sales of investments | 13,601 | 10,023 |
Maturities of investments | 33,740 | 29,195 |
Purchase of property and equipment | (428) | (513) |
Net cash provided by (used in) investing activities | (2,164) | 3,122 |
Cash flows from financing activities: | ||
Stock repurchase | (1,000) | |
Proceeds from exercise of stock options and employee stock purchase plan | 1,912 | 2,938 |
Payment for intangible asset | (1,205) | (995) |
Net cash provided by (used in) financing activities | (293) | 1,943 |
Net increase in cash, cash equivalents and restricted cash | 5,182 | 10,397 |
Cash, cash equivalents and restricted cash at beginning of period | 231,412 | 194,058 |
Cash, cash equivalents and restricted cash at end of period | 236,594 | 204,455 |
Supplemental disclosure of cash flow information: | ||
Cash paid for income taxes | 370 | 797 |
Supplemental disclosure of noncash investing and financing activities: | ||
Unpaid liabilities related to intangible and fixed assets additions | $ 67 | $ 372 |
Organization and Summary of Sig
Organization and Summary of Significant Accounting Policies | 3 Months Ended |
Apr. 30, 2020 | |
Accounting Policies [Abstract] | |
Organization and Summary of Significant Accounting Policies | 1. Organization and Summary of Significant Accounting Policies Organization Ambarella, Inc. (the “Company”) was incorporated in the Cayman Islands on January 15, 2004. The Company is a leading developer of low-power semiconductor solutions offering high-definition (HD) and Ultra HD compression, image processing, and deep neural network processing. The Company combines its processor design capabilities with its expertise in video and image processing, algorithms and software to provide a technology platform that is designed to be easily scalable across multiple applications and enable rapid and efficient product development. The Company’s system-on-a-chip, or SoC, designs fully integrated high-definition video processing, image processing, artificial intelligence (AI) computer vision algorithms, audio processing and system functions onto a single chip, delivering exceptional video and image quality, differentiated functionality and low power consumption. The Company is currently addressing a broad range of human and computer vision applications, including professional and consumer security cameras, automotive cameras such as advanced driver assistance systems (ADAS), electronic mirrors, drive recorders, driver/cabin monitoring systems, autonomous driving, and industrial and robotic applications. The Company sells its solutions to leading original design manufacturers, or ODMs, and original equipment manufacturers, or OEMs, globally. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared by the Company in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and notes normally provided in audited financial statements. The accounting policies are described in the “Notes to Consolidated Financial Statements” in the Annual Report on Form 10-K for the 2020 fiscal year filed with the SEC on March 27, 2020 (the “Form 10-K”) and updated, as necessary, in this Form 10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States (“U.S. GAAP”). In the opinion of management, all adjustments (consisting of normal recurring accruals and adjustments) considered necessary for a fair statement have been included. The results of operations for any interim period are not necessarily indicative of, nor comparable to, the results of operations for any other interim period or for a full fiscal year. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Form 10-K. Basis of Consolidation The Company’s fiscal year ends on January 31. The condensed consolidated financial statements of the Company and its subsidiaries have been prepared in conformity with U.S. GAAP. All intercompany transactions and balances have been eliminated upon consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates. On an ongoing basis, management evaluates its estimates and assumptions, including those related to (i) the collectability of accounts receivable; (ii) write down of excess and obsolete inventories; (iii) intangible assets and goodwill; (iv) the estimated useful lives of long-lived assets; (v) impairment of long-lived assets and financial instruments; (vi) warranty obligations; (vii) the valuation of stock-based compensation awards and financial instruments; (viii) the probability of performance objectives achievement; (ix) the realization of tax assets and estimates of tax liabilities, including reserves for uncertain tax positions; and (x) the recognition and disclosure of contingent liabilities. These estimates and assumptions are based on historical experience and on various other factors which the Company believes to be reasonable under the circumstances. The Company may engage third-party valuation specialists to assist with estimates related to the valuation of financial instruments, assets and stock awards associated with various contractual arrangements. Such estimates often require the selection of appropriate valuation methodologies and significant judgment. Actual results could differ from these estimates under different assumptions or circumstances and such differences could be material. The Company also assessed the impacts of COVID-19 on the above accounting matters as of April 30, 2020 and through the date of this report. While there was not a material impact as of and for the quarter ended April 30, 2020, future actual magnitude and duration of COVID-19, as well as other associated factors, could r esult in material negative impacts to its condensed consolidated financial statements in future reporting periods. Concentration of Risk The Company’s products are manufactured, assembled and tested by third-party contractors located primarily in Asia. The Company does not have long-term agreements with these contractors. A significant disruption in the operations of one or more of these contractors would impact the production of the Company’s products which could have a material adverse effect on its business, financial condition and results of operations. A substantial portion of the Company’s revenue is derived from sales through one of its distributors, Wintech Microelectronics Co., Ltd., or Wintech, which serves as its non-exclusive sales representative in Asia other than Japan, and directly to one ODM customer, Chicony Electronics Co., Ltd., or Chicony. Termination of the relationships with these customers could result in a temporary or permanent loss of revenue. Furthermore, any credit issues from these customers could impair their abilities to make timely payment to the Company. See Note 14 for additional information regarding revenue and credit concentration with these customers. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, marketable debt securities and accounts receivable. The Company maintains its cash primarily in checking accounts with reputable financial institutions. Cash deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on deposits of its cash. In order to limit the exposure of each investment, the cash equivalents and marketable debt securities consist primarily of money market funds, asset-backed securities, commercial paper, U.S. government securities and debt securities of corporations which management assesses to be highly liquid. The Company does not hold or issue financial instruments for trading purposes. The Company performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and customers’ credit worthiness. The Company regularly monitors collections and payments from its customers. Financial Instruments On February 1, 2020, the Company adopted Accounting Standards Update (ASU) No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, using the modified retrospective transition method. Under this new guidance, the Company recognizes credit losses based on a forward-looking current expected credit losses (CECL) model instead of the previous incurred loss model for financial instruments, including accounts receivable. The Company’s accounts receivable are recorded at invoiced amount less an allowance for any potentially uncollectible amounts. Accordingly, the Company makes estimates of expected credit losses for the allowance for doubtful accounts based upon its assessment of various factors, including historical collection experience, the age of the accounts receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The Company considers all highly liquid debt security investments with original maturities of less than three months at the time of purchase to be cash equivalents. Debt security investments that are highly liquid with original maturities at the time of purchase greater than three months are considered marketable debt securities. The Company classifies these investments as “available-for-sale” (AFS) securities. Instead of the previous "other than temporary" impairment model, the Company now estimates the expected losses whenever a security’s fair value is below its amortized cost basis. The expected loss is computed at an individual security level using the discounted cash flow method with the effective interest rate on the purchase date. In the determination of credit-related losses, the Company excludes securities with zero loss expectation such as assets backed by government agencies. There are various factors considered in its assessment of credit-related losses, including the extent to which the fair value is less than the amortized cost basis, adverse conditions related to an industry or an underlying loan obligator, the payment structure of the security, changes to the rating of the security and other factors that may affect the security credit. The credit-related portion of the loss is recognized in other income, net in the condensed consolidated statements of operations but is limited to the difference between the fair value and the amortized cost basis of the security, adjusted for accrued interest. The non-credit-related portion of the loss is recognized in accumulated other comprehensive income in the condensed consolidated balance sheets. The cumulative effect adjustment upon the adoption on February 1, 2020 was immaterial. The credit-related losses and associated allowance amount from the Company’s financial instruments were not material as of April 30, 2020, respectively. Restricted Cash Amounts included in restricted cash represent those required to be set aside to secure certain transactions in a foreign entity. As of April 30, 2020 and January 31, 2020, the restricted cash was immaterial. The following table presents cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheets, and the sums are presented on the condensed consolidated statements of cash flows: As of April 30, 2020 January 31, 2020 April 30, 2019 January 31, 2019 (in thousands) Cash and cash equivalents $ 236,585 $ 231,403 $ 204,444 $ 194,047 Restricted cash 9 9 11 11 Total as presented in the consolidated statements of cash flows $ 236,594 $ 231,412 $ 204,455 $ 194,058 Inventories The Company records inventories at the lower of cost or net realizable value. The cost includes materials and other production costs and is computed using standard cost on a first-in, first-out basis. Inventory reserves are recorded for estimated obsolescence or unmarketable inventories based on forecast of future demand and market conditions. Any adjustments to reduce the cost of inventories to their net realizable value are recognized in earnings in the current period. Noncancelable Internal-Use Software License The Company accounts for a noncancelable on premise internal-use software license as the acquisition of an intangible asset and the incurrence of a liability to the extent that all or a portion of the software licensing fees are not paid on or before the license acquisition date. The intangible asset and related liability are recorded at net present value and interest expense is recorded over the payment term. Leases Effective February 1, 2019, the Company adopted Accounting Standards Codification (“ASC”) Topic 842, Leases. As a result, the Company recognizes leases as operating lease right-of-use (“ROU”) assets and corresponding lease liabilities at the lease commencement date based on the present value of future lease payments, while recognizing lease expenses under straight-line method through the lease term. The Company also elected the practical expedient that does not recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases. The Company does not combine lease components with non-lease components, and as a result, the non-lease components are accounted for separately. In determining the present value of lease payments, the Company uses the implicit interest rate if readily determinable. When the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at the lease commencement date. The Company's leases mainly include its worldwide office facilities which are all classified as operating leases. Certain leases include renewal options that are under the Company's discretion. The renewal options are included in the ROU and liability calculation if it is reasonably certain that the Company will exercise the option. The Company's finance leases are immaterial as of April 30, 2020 and January 31, 2020, respectively. Revenue Recognition The Company adopted ASC 606, Revenue from Contracts with Customers. As a result, the Company recognizes revenue when control of its goods and services is transferred to its customers. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied. The sale of semiconductor products accounts for the substantial majority of the Company’s consolidated revenue. Sales agreements with customers are renewable periodically and contain terms and conditions with respect to payment, delivery, warranty, supply and other rights. The Company considers an accepted customer purchase order, governed by sales agreement, to be the contract with the customer. For each contract, the Company considers the promise to transfer tangible products to be the identified performance obligation. Product sales contracts may include volume-based tiered pricing or rebates that are fulfilled in cash or product. In determining the transaction price, the Company accounts for the right of returns, cash rebates, commissions and other pricing adjustments as variable consideration , estimates these amounts based on the expected amount to be provided to customers and reduces the revenue recognized. The Company estimates sales returns and rebates based on the Company’s historical patterns of return and pricing credits. As the Company’s standard payment terms are 30 days to 60 days, the contracts have no financing component. Under ASC 606, the Company estimates the total consideration to be received by using the expected value method for each contract, computes weighted average selling price for each unit shipped in cases where there is a material right due to the presence of volume-based tiered pricing, allocates the total consideration between the identified performance obligations, and recognizes revenue when control of its goods and services is transferred to its customers. The Company considers product control to be transferred at a point in time upon shipment or delivery because the Company has a present right to payment at that time, the customer has legal title to the asset, the Company has transferred physical possession of the asset, and the customer has significant risk and rewards of ownership of the asset . The Company also enters into fixed-price engineering service agreements with certain customers. These agreements may include multiple performance obligations, such as software development services, licensing of intellectual property and post-contract customer support, or PCS. These multiple performance obligations are highly interdependent, highly interrelated, are typically not sold separately and do not have standalone selling prices. They are all inputs to generate one combined output which is incorporating the Company’s SoC into the customer’s product. Accordingly, the Company determines that they are not separately identifiable and shall be treated as a single performance obligation. Customers usually pay based on milestones achieved. Because payments received do not correspond directly with the value of the Company’s performance to date, for fixed-price engineering services arrangements, revenue is recognized using the time-based straight line method, which best depicts the Company’s performance toward complete satisfaction of the performance obligation based on the nature of such professional services. Revenues from engineering service agreements were not material for the three months ended April 30, 2020 and 2019, respectively. Timing of revenue recognition may differ from the timing of invoicing to the Company’s customers. The Company records contract assets when revenue is recognized prior to invoicing. The Company’s contract assets are primarily related to satisfied but unbilled performance obligations associated with its engineering service agreements at the reporting date. As of April 30, 2020 and January 31, 2020, the contract assets for these unbilled receivables were not material. The Company’s contract liabilities consist of deferred revenue. The deferred revenue is primarily related to the portion of a transaction price that exceeds the weighted average selling price for products sold to date under tiered-pricing contracts which contain material rights. This deferred revenue is expected to be recognized over the course of the contract when products are delivered for future pricing below the weighted average selling price of the contract. For the three months ended April 30, 2020 and 2019, the Company did not recognize any material revenue adjustment, respectively, related to performance obligations satisfied in prior periods released from this deferred revenue. As of April 30, 2020 and January 31, 2020, the respective deferred revenues were not material. Additionally, the transaction price allocated to unsatisfied, or partially unsatisfied, purchase orders for contracts that are greater than a year was not material as of April 30, 2020 and January 31, 2020, respectively. The Company also elects not to disclose the value of unsatisfied or partially unsatisfied performance obligations due to original expected contract duration of one year or less and elects to exclude amounts collected from customers for all sales taxes from the transaction price Cost of Revenue Cost of revenue includes cost of materials, cost associated with packaging and assembly, testing and shipping, cost of personnel, stock-based compensation, logistics and quality assurance, warranty cost, royalty expense, write-downs of inventories and allocation of overhead. Research and Development Research and development costs are expensed as incurred and consist primarily of personnel costs, product development costs, which include engineering services, development software and hardware tools, license fees, costs of fabrication of masks for prototype products, other development materials costs, depreciation of equipment and tools and allocation of facility costs, net of any research and development grants. As of April 30, 2020, there was approximately $1.2 million of grants recorded in prepaid expenses and other current assets and approximately $2.8 million of grants recorded in other non-current assets in the condensed consolidated balance sheets. Income Taxes The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. In estimating future tax consequences, generally all expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized. The Company applies authoritative guidance for the accounting for uncertainty in income taxes. The guidance requires that tax effects of a position be recognized only if it is “more likely than not” to be sustained based solely on its technical merits as of the reporting date. Upon estimating its tax positions and tax benefits, the Company considers and evaluates numerous factors, which may require periodic adjustments and which may not reflect the final tax liabilities. The Company adjusts its financial statements to reflect only those tax positions that are more likely than not to be sustained under examination. As part of the process of preparing condensed consolidated financial statements, the Company is required to estimate its taxes in each of the jurisdictions in which it operates. The Company estimates actual current tax exposure together with assessing temporary differences resulting from differing treatment of items, such as accruals and allowances not currently deductible for tax purposes. These differences result in deferred tax assets, which are included in the condensed consolidated balance sheets. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the condensed consolidated statements of operations become deductible expenses under applicable income tax laws, or loss or credit carryforwards are utilized. In assessing whether deferred tax assets may be realized, the Company considers whether it is more likely than not that some portion or all of deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. The Company makes estimates and judgments about its future taxable income based on assumptions that are consistent with its plans and estimates. Should the actual amounts differ from estimates, the amount of valuation allowance could be materially impacted. Any adjustment to the deferred tax asset valuation allowance would be recorded in the condensed consolidated income statement for the periods in which the adjustment is determined to be required. Net Income (Loss) Per Ordinary Share Basic earnings (losses) per share is computed by dividing net income (loss) available to ordinary shareholders by the weighted-average number of ordinary shares outstanding during the period. Diluted earnings (losses) per share is computed by dividing net income (loss) available to ordinary shareholders by the weighted-average number of ordinary shares outstanding during the period increased to include the number of additional ordinary shares that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan, unvested restricted stock and restricted stock units. The dilutive effect of potentially dilutive securities is reflected in diluted earnings (losses) per share by application of the treasury stock method. Comprehensive Income (Loss) Comprehensive income (loss) includes unrealized gains or losses from available-for-sale securities that are excluded from net income (loss). Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The amendments are effective for public entities in fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The Company did not early adopt and believes the adoption of this new guidance will not have a material impact on its consolidated financial statements and disclosures. There were no other significant updates to the recently issued accounting standards other than as disclosed above. |
Financial Instruments and Fair
Financial Instruments and Fair Value | 3 Months Ended |
Apr. 30, 2020 | |
Investments All Other Investments [Abstract] | |
Financial Instruments and Fair Value | 2. Financial Instruments and Fair Value The Company invests a portion of its cash in debt securities that are denominated in United States dollars. The investment portfolio consists of money market funds, asset-backed securities, commercial paper, U.S. government securities, and debt securities of corporations. All of the investments are classified as available-for-sale securities and reported at fair value in the condensed consolidated balance sheets as follows: As of April 30, 2020 Amortized Unrealized Unrealized Losses Fair Value (in thousands) Money market funds $ 2,011 $ — $ — $ 2,011 Commercial paper 61,902 — — 61,902 Corporate bonds 103,681 726 (599 ) 103,808 Asset-backed securities 23,742 152 (18 ) 23,876 U.S. government securities 20,059 144 — 20,203 Total cash equivalents and marketable debt securities $ 211,395 $ 1,022 $ (617 ) $ 211,800 As of January 31, 2020 Amortized Unrealized Gains Unrealized Losses Fair Value (in thousands) Money market funds $ 8,284 $ — $ — $ 8,284 Commercial paper 63,390 — — 63,390 Corporate bonds 95,053 653 — 95,706 Asset-backed securities 23,062 69 (2 ) 23,129 U.S. government securities 20,524 48 — 20,572 Total cash equivalents and marketable debt securities $ 210,313 $ 770 $ (2 ) $ 211,081 As of April 30, 2020, there were no debt securities with unrealized losses for more than twelve months. As of April 30, 2020 January (in thousands) Included in cash equivalents $ 37,058 $ 37,736 Included in marketable debt securities 174,742 173,345 Total cash equivalents and marketable debt securities $ 211,800 $ 211,081 The contractual maturities of the investments at April 30, 2020 and January 31, 2020 were as follows: As of April 30, 2020 January (in thousands) Due within one year $ 144,722 $ 146,267 Due within one to three years 67,078 64,814 Total cash equivalents and marketable debt securities $ 211,800 $ 211,081 The unrealized losses on the available-for-sale securities were primarily caused by fluctuations in market value and interest rates as a result of the economic environment. Upon adoption of ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company estimates the expected losses at an individual security level whenever a security’s fair value is below its amortized cost basis using the discounted cash flow method. The credit-related portion of the loss is recognized in other income, net in the condensed consolidated statements of operations but is limited to the difference between the fair value and the amortized cost basis of the security, adjusted for accrued interest. The non-credit-related portion of the loss is recognized in accumulated other comprehensive income in the condensed consolidated balance sheets. The credit-related losses of the Company’s financial instruments were not material as of April 30, 2020. The following fair value hierarchy is applied for disclosure of the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2— Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments . Level 3—Unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The Company measures the fair value of money market funds using quoted prices in active markets for identical assets and classifies them within Level 1. The fair value of the Company’s investments in other debt securities are obtained based on quoted prices for similar assets in active markets and are classified within Level 2. The following tables present the fair value of the financial instruments measured on a recurring basis as of April 30, 2020 and January 31, 2020, respectively: As of April 30, 2020 Total Level 1 Level 2 Level 3 (in thousands) Money market funds $ 2,011 $ 2,011 $ — $ — Commercial paper 61,902 — 61,902 — Corporate bonds 103,808 — 103,808 — Asset-backed securities 23,876 — 23,876 — U.S. government securities 20,203 — 20,203 — Total cash equivalents and marketable debt securities $ 211,800 $ 2,011 $ 209,789 $ — As of January 31, 2020 Total Level 1 Level 2 Level 3 (in thousands) Money market funds $ 8,284 $ 8,284 $ — $ — Commercial paper 63,390 — 63,390 — Corporate bonds 95,706 — 95,706 — Asset-backed securities 23,129 — 23,129 — U.S. government securities 20,572 — 20,572 — Total cash equivalents and marketable debt securities $ 211,081 $ 8,284 $ 202,797 $ — |
Inventories
Inventories | 3 Months Ended |
Apr. 30, 2020 | |
Inventory Disclosure [Abstract] | |
Inventories | 3. Inventories Inventories at April 30, 2020 and January 31, 2020 consisted of the following: As of April 30, 2020 January (in thousands) Work-in-progress $ 12,773 $ 10,133 Finished goods 9,184 12,838 Total $ 21,957 $ 22,971 |
Property and Equipment, Net
Property and Equipment, Net | 3 Months Ended |
Apr. 30, 2020 | |
Property Plant And Equipment [Abstract] | |
Property and Equipment, Net | 4. Property and Equipment, Net Depreciation expense was approximately $0.7 million for the three months ended April 30, 2020 and 2019, respectively. Property and equipment at April 30, 2020 and January 31, 2020 consisted of the following: As of April 30, 2020 January (in thousands) Computer equipment and software $ 10,598 $ 10,282 Machinery and equipment 6,377 6,317 Furniture and fixtures 969 969 Leasehold improvements 2,380 2,356 Construction in progress 70 63 20,394 19,987 Less: accumulated depreciation and amortization (14,993 ) (14,373 ) Total property and equipment, net $ 5,401 $ 5,614 |
Intangible Assets, Net
Intangible Assets, Net | 3 Months Ended |
Apr. 30, 2020 | |
Goodwill And Intangible Assets Disclosure [Abstract] | |
Intangible Assets, Net | 5. Intangible Assets, Net The intangible assets primarily consist of $4.1 million of in-process research and development (“IPR&D”) from the acquisition of VisLab S.r.l., or VisLab, The Company enters into certain internal-use noncancelable software license agreements with third parties from time-to-time. The licenses have been capitalized as intangible assets, and the corresponding future payments have been recorded as liabilities at net present value. As of April 30, 2020, $4.4 million was recorded in accrued and other current liabilities and $7.0 million was recorded in other long-term liabilities in the condensed consolidated balance sheets. The carrying amounts of intangible assets as of April 30, 2020 and January 31, 2020 were as follows : As of April 30, 2020 As of January 31, 2020 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) In-process research and development $ 4,100 $ — $ 4,100 $ 4,100 $ — $ 4,100 Internal-use software licenses 27,291 (15,000 ) 12,291 27,203 (13,477 ) 13,726 Total acquired intangible assets $ 31,391 $ (15,000 ) $ 16,391 $ 31,303 $ (13,477 ) $ 17,826 The amortization expense related to these software licenses was approximately $1.5 million and $1.3 million for the three months ended April 30, 2020 and 2019, respectively. The estimated future amortization expense of these software licenses as of April 30, 2020 is as follows: As of April 30, 2020 Fiscal Year (in thousands) 2021 (9 months remaining) $ 4,319 2022 4,553 2023 3,419 2024 — 2025 — Thereafter — Total future amortization expenses: $ 12,291 IPR&D is required to be tested for impairment at least annually in the fourth fiscal quarter or sooner whenever events or changes in circumstances indicate that the assets may be impaired. There were no intangible asset impairments for the three months ended April 30, 2020 and 2019, respectively. |
Accrued and Other Current Liabi
Accrued and Other Current Liabilities | 3 Months Ended |
Apr. 30, 2020 | |
Payables And Accruals [Abstract] | |
Accrued and Other Current Liabilities | 6. Accrued and Other Current Liabilities Accrued and other current liabilities at April 30, 2020 and January 31, 2020 consisted of the following: As of April 30, 2020 January (in thousands) Accrued employee compensation $ 9,949 $ 16,874 Accrued rebates 90 54 Accrued product development costs 10,454 10,885 Software license liabilities, current 4,386 4,388 Other accrued liabilities 2,383 2,769 Total accrued and other current liabilities $ 27,262 $ 34,970 The decrease in employee compensation liabilities was primarily due to $7.7 million of annual bonus paid in March 2020, of which $2.3 million was paid in cash and $5.4 million was settled with restricted stock units. |
Leases
Leases | 3 Months Ended |
Apr. 30, 2020 | |
Leases [Abstract] | |
Leases | 7. Leases The Company has entered into various operating leases for its worldwide office facilities and recorded approximately $0.7 million of operating lease expense for the three months ended April 30, 2020 and 2019, respectively. The Company's short-term leases and finance leases were not material as of April 30, 2020 and January 31, 2020, respectively . Supplemental cash flow information related to leases is as follows: Three Months Ended April 30, 2020 (in thousands) Cash paid for operating leases included in operating cash flows $ 689 Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets $ 88 As of April 30, 2020, the weighted average remaining lease term is 4.90 years, and the weighted average discount rate is 4.43 percent. Future minimum lease payments for the lease liabilities are as follows : As of April 30, 2020 Fiscal Year (in thousands) 2021 (9 months remaining) $ 1,784 2022 2,355 2023 1,644 2024 1,693 2025 1,740 Thereafter 1,208 Total future annual minimum lease payments 10,424 Less: interest (937 ) Total lease liabilities $ 9,487 |
Other Long-Term Liabilities
Other Long-Term Liabilities | 3 Months Ended |
Apr. 30, 2020 | |
Other Liabilities Disclosure [Abstract] | |
Other Long-Term Liabilities | 8. Other Long-Term Liabilities Other long-term liabilities at April 30, 2020 and January 31, 2020 consisted of the following: As of April 30, 2020 January (in thousands) Unrecognized tax benefits, including interest $ 8,782 $ 8,261 Deferred tax liabilities, non-current 1,287 1,288 Software license liabilities, non-current 7,046 8,159 Other long-term liabilities 146 68 Total other long-term liabilities $ 17,261 $ 17,776 |
Capital Stock
Capital Stock | 3 Months Ended |
Apr. 30, 2020 | |
Equity [Abstract] | |
Capital Stock | 9. Capital Stock Preference shares After completion of the Company’s initial public offering in 2012, a total of 20,000,000 preference shares, with a $0.00045 par value per share, were authorized. There were no preference shares issued and outstanding as of April 30, 2020 and January 31, 2020, respectively. Ordinary shares As of April 30, 2020 and January 31, 2020, a total of 200,000,000 ordinary shares were authorized. On February 1, 2020, the Company added 1,521,252 ordinary shares to the ordinary shares reserved for issuance, pursuant to an “evergreen” provision contained in the 2012 Equity Incentive Plan, or EIP. Pursuant to such provision, for each fiscal year, the number of ordinary shares reserved for issuance under the EIP is automatically increased by a number equal to the lesser of (i) 3,500,000 ordinary shares, (ii) four and one half percent (4.5%) of the aggregate number of ordinary shares outstanding on January 31st of the preceding fiscal year, or (iii) a lesser number of shares that may be determined by the Company’s Board of Directors. On February 1, 2020, the Company added 422,570 ordinary shares to the ordinary shares reserved for issuance, pursuant to an “evergreen” provision contained in the Amended and Restated 2012 Employee Stock Purchase Plan, or ESPP. Pursuant to such provision, for each fiscal year, the number of ordinary shares reserved for issuance under the ESPP is automatically increased by a number equal to the lesser of (i) 1,500,000 ordinary shares, (ii) one and one quarter percent (1.25%) of the aggregate number of ordinary shares outstanding on such date, or (iii) an amount determined by the Company’s Board of Directors or a duly authorized committee of the Board of Directors. As of April 30, 2020 and January 31, 2020, the following ordinary shares were reserved for future issuance under the EIP and ESPP: As of April 30, 2020 January 31, 2020 Shares reserved for options, restricted stock and restricted stock units under EIP 7,087,717 6,045,108 Shares reserved for ESPP 2,398,510 2,059,504 Shares repurchased On March 16, 2020, the Company repurchased a total of 25,719 shares for approximately $1.0 million in cash. Since the inception of the repurchase programs in June 2016, a total of $275.0 million has been authorized, and a total of 4,011,595 shares have been repurchased for approximately $175.8 million in cash. Repurchases may be made from time-to-time through open market purchases, 10b5-1 plans or privately negotiated transactions subject to market conditions, applicable legal requirements and other relevant factors. The repurchase program does not obligate the Company to acquire any particular amount of ordinary shares, and it may be suspended at any time at the Company’s discretion. The repurchase program is funded using the Company’s working capital and any repurchased shares are recorded as authorized but unissued shares. As of April 30, 2020, there was $49.0 million available for repurchases under the repurchase program through June 30, 2020. |
Stock-based Compensation
Stock-based Compensation | 3 Months Ended |
Apr. 30, 2020 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Stock-based Compensation | 10. Stock-based Compensation The following table presents the classification of stock-based compensation for the periods indicated: Three Months Ended April 30, 2020 2019 (in thousands) Stock-based compensation: Cost of revenue $ 297 $ 267 Research and development 9,896 10,204 Selling, general and administrative 5,843 5,989 Total stock-based compensation $ 16,036 $ 16,460 During the three months ended April 30, 2020, approximately $0.8 million of stock-based compensation expense was accrued in the accrued and other current liabilities in the condensed consolidated balance sheets. As of April 30, 2020, total unrecognized compensation cost related to unvested stock options was $3.5 million and is expected to be recognized over a weighted-average period of 2.39 years. Total unrecognized compensation cost related to unvested restricted stock units was $122.8 million and is expected to be recognized over a weighted-average period of 2.42 years. The following table sets forth the weighted-average assumptions used to estimate the fair value of stock options and employee stock purchase plan awards for the periods indicated: Three Months Ended April 30, 2020 2019 Stock Options: Volatility 50 % 52 % Risk-free interest rate 0.74 % 2.49 % Expected term (years) 5.89 5.88 Dividend yield 0 % 0 % Employee stock purchase plan awards: Volatility 61 % 48 % Risk-free interest rate 0.29 % 2.52 % Expected term (years) 0.5 0.5 Dividend yield 0 % 0 % The following table summarizes stock option activities for the period indicated: Option Outstanding Weighted- Total Average Weighted- Value Of Remaining Aggregate Weighted- Average Options Contractual Intrinsic Average Grant-date Exercised Term Value Shares Exercise Fair Value (in (in years) (in Outstanding at January 31, 2020 1,124,646 $ 32.93 Granted 7,200 50.77 $ 23.85 Exercised (75,870 ) 14.66 $ 3,369 Forfeited (2,929 ) 47.68 Expired (350 ) 40.60 Outstanding at April 30, 2020 1,052,697 34.33 4.28 $ 22,404 Exercisable at April 30, 2020 903,782 $ 31.92 3.59 $ 21,555 The intrinsic value of options outstanding and exercisable is calculated based on the difference between the fair market value of the Company’s ordinary shares on the reporting date and the exercise price. The closing price of the Company’s ordinary shares on April 30, 2020 was $52.58, as reported by The NASDAQ Global Market. The intrinsic value of exercised options is calculated based on the difference between the fair market value of the Company’s ordinary shares on the exercise date and the exercise price. The following table summarizes the restricted stock units activities for the period indicated: Weighted- Average Grant-Date Shares Fair Value Unvested at January 31, 2020 2,617,266 $ 50.30 Granted 505,261 53.26 Vested (402,773 ) 51.89 Forfeited (36,338 ) 54.75 Unvested at April 30, 2020 2,683,416 $ 50.56 As of April 30, 2020, the aggregate intrinsic value of unvested restricted stock units was $141.1 million. |
Net Loss Per Ordinary Share
Net Loss Per Ordinary Share | 3 Months Ended |
Apr. 30, 2020 | |
Earnings Per Share [Abstract] | |
Net Loss Per Ordinary Share | 11. Net Loss Per Ordinary Share The following table sets forth the computation of basic and diluted loss per ordinary share for the periods indicated: Three 2020 2019 (in thousands, except share and per share data) Numerator: Net loss $ (15,463 ) $ (17,311 ) Denominator: Weighted-average ordinary shares - basic 34,080,330 32,492,044 Weighted-average ordinary shares - diluted 34,080,330 32,492,044 Net loss per ordinary share: Basic $ (0.45 ) $ (0.53 ) Diluted $ (0.45 ) $ (0.53 ) The following weighted-average potentially dilutive securities were excluded from the computation of diluted loss per ordinary share as their effect would have been antidilutive: Three Months Ended April 30, 2020 2019 Options to purchase ordinary shares 771,769 1,003,060 Restricted stock and restricted stock units 1,441,462 926,156 Employee stock purchase plan 31,092 17,469 2,244,323 1,946,685 |
Income Taxes
Income Taxes | 3 Months Ended |
Apr. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 12. Income Taxes The following table provides details of income taxes for the periods indicated: Three Months Ended April 30, 2020 2019 (in thousands) Loss before income taxes $ (14,337 ) $ (16,045 ) Provision for income taxes 1,126 1,266 Effective tax rate (7.9)% (7.9)% The Company recorded an income tax provision of $1.1 million and $1.3 million for the three months ended April 30, 2020 and 2019, respectively. The decrease in income tax expense was primarily due to a decrease in loss before income taxes as compared to the same period in the prior fiscal year, partially offset by a decrease in the proportion of profits generated in lower tax jurisdictions. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), P.L. 116-136, was passed into law, amending portions of certain relevant US tax laws. The CARES Act includes a number of federal income tax law changes, including, but not limited to: 1) permitting net operating loss carrybacks to offset 100% of taxable income for taxable years beginning before 2021, 2) accelerating alternative minimum tax credit refunds, 3) temporarily increasing the allowable business interest deduction from 30% to 50% of adjusted taxable income, and 4) providing a technical correction for depreciation related to qualified improvement property. The CARES Act also provides for an Employee Retention Credit, a fully refundable payroll tax credit for certain eligible employers, and the ability for all eligible employers to defer payment of the employer share of payroll taxes owed on wages paid for the period ending December 31, 2020. The Company has preliminarily evaluated the impact of the CARES Act and does not expect it will have a material impact on the Company’s condensed consolidated financial statements. The Company files federal and state income tax returns in the United States and in various foreign jurisdictions. The tax years 2013 to 2019 remain open to examination by U.S. federal tax authorities. The tax years 2009 to 2019 remain open to examination by U.S. state tax authorities. The tax years 2014 to 2019 remain open to examination by foreign tax authorities. Fiscal years outside of the normal statute of limitations remain open to audit by tax authorities due to tax attributes generated in those earlier years, which have been carried forward and may be audited in subsequent years when utilized. The Company regularly assesses the likelihood of adverse outcomes resulting from potential tax examinations to determine the adequacy of its provision for income taxes. These assessments can require considerable estimates and judgments. As of April 30, 2020, the gross amount of unrecognized tax benefits was approximately $43.3 million. If the estimates of income tax liabilities prove to be less than the ultimate assessment, then a further charge to expense could be required. If events occur, and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities could result in tax benefits being recognized in the period in which the Company determines the liabilities are no longer necessary. The Company does not anticipate significant changes to its uncertain tax positions during the next twelve months. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Apr. 30, 2020 | |
Commitments And Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 13. Commitments and Contingencies Contract Manufacturer Commitments The Company’s components and products are procured and built by independent contract manufacturers based on sales forecasts. These forecasts include estimates of future demand, historical trends, analysis of sales and marketing activities, and adjustment of overall market conditions. The Company regularly issues purchase orders to independent contract manufacturers which are cancelable upon agreement between the Company and the third-party manufacturers. As of April 30, 2020 and January 31, 2020, total manufacturing purchase commitments were approximately $32.6 million and $35.9 million, respectively. Indemnification The Company, from time to time, in the normal course of business, indemnifies certain vendors with whom it enters into contractual relationships. The Company has agreed to hold the other party harmless against third-party claims in connection with the Company’s future products. The Company also indemnifies certain customers against third-party claims related to certain intellectual property and product liability matters. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim. The Company has not made payments under these obligations, and no liabilities have been recorded for these obligations in the condensed consolidated balance sheets as of April 30, 2020 and January 31, 2020, respectively. |
Segment Reporting
Segment Reporting | 3 Months Ended |
Apr. 30, 2020 | |
Segment Reporting [Abstract] | |
Segment Reporting | 14. Segment Reporting The Company operates in one reportable segment related to the development and sales of low-power, high-definition (HD), Ultra HD video compression, image processing and computer vision solutions. The Chief Executive Officer of the Company has been identified as the Chief Operating Decision Maker (the “CODM”) and manages the Company’s operations as a whole. For the purpose of evaluating financial performance and allocating resources, the CODM reviews financial information presented on a consolidated basis accompanied by information by customer and geographic region. Geographic Revenue The following table sets forth the Company’s revenue by geographic region based on bill-to location for the periods indicated: Three Months Ended April 30, 2020 2019 (in thousands) Taiwan $ 34,460 $ 27,600 Asia Pacific 14,028 14,488 Europe 2,253 3,483 North America other than United States 2,673 883 United States 1,231 734 Total revenue $ 54,645 $ 47,188 As of April 30, 2020, substantially all of the Company’s property and equipment, net, was located in the United States, Asia Pacific region and Europe with approximate net amounts of $1.7 million, $2.6 million and $1.0 million, respectively. Major Customers The customers representing 10% or more of revenue and accounts receivable were Wintech and Chicony, which accounted for approximately 63% and 15% of total revenue for the three months ended April 30, 2020, respectively. For the three months ended April 30, 2019, the customers representing 10% or more of revenue and accounts receivable were Wintech and Chicony, which accounted for approximately 59% and 18% of total revenue, respectively. Accounts receivable with Wintech and Chicony was approximately |
Subsequent Events
Subsequent Events | 3 Months Ended |
Apr. 30, 2020 | |
Subsequent Events [Abstract] | |
Subsequent Events | 15. Subsequent Events On May 29, 2019, the Company’s Board of Directors authorized a program to repurchase up to $50.0 million of the Company’s ordinary shares through June 30, 2020. On May 29, 2020, the Board approved an extension of this program for an additional twelve months ending June 30, 2021. The repurchase program does not obligate the Company to acquire any particular amount of ordinary shares, and it may be suspended at any time at the Company’s discretion. As of June 5, 2020, there were 25,719 shares repurchased and approximately $49.0 million available for repurchases under the program. |
Organization and Summary of S_2
Organization and Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Apr. 30, 2020 | |
Accounting Policies [Abstract] | |
Organization | Organization Ambarella, Inc. (the “Company”) was incorporated in the Cayman Islands on January 15, 2004. The Company is a leading developer of low-power semiconductor solutions offering high-definition (HD) and Ultra HD compression, image processing, and deep neural network processing. The Company combines its processor design capabilities with its expertise in video and image processing, algorithms and software to provide a technology platform that is designed to be easily scalable across multiple applications and enable rapid and efficient product development. The Company’s system-on-a-chip, or SoC, designs fully integrated high-definition video processing, image processing, artificial intelligence (AI) computer vision algorithms, audio processing and system functions onto a single chip, delivering exceptional video and image quality, differentiated functionality and low power consumption. The Company is currently addressing a broad range of human and computer vision applications, including professional and consumer security cameras, automotive cameras such as advanced driver assistance systems (ADAS), electronic mirrors, drive recorders, driver/cabin monitoring systems, autonomous driving, and industrial and robotic applications. The Company sells its solutions to leading original design manufacturers, or ODMs, and original equipment manufacturers, or OEMs, globally. |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared by the Company in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and notes normally provided in audited financial statements. The accounting policies are described in the “Notes to Consolidated Financial Statements” in the Annual Report on Form 10-K for the 2020 fiscal year filed with the SEC on March 27, 2020 (the “Form 10-K”) and updated, as necessary, in this Form 10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States (“U.S. GAAP”). In the opinion of management, all adjustments (consisting of normal recurring accruals and adjustments) considered necessary for a fair statement have been included. The results of operations for any interim period are not necessarily indicative of, nor comparable to, the results of operations for any other interim period or for a full fiscal year. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Form 10-K. |
Basis of Consolidation | Basis of Consolidation The Company’s fiscal year ends on January 31. The condensed consolidated financial statements of the Company and its subsidiaries have been prepared in conformity with U.S. GAAP. All intercompany transactions and balances have been eliminated upon consolidation. |
Use of Estimates | Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates. On an ongoing basis, management evaluates its estimates and assumptions, including those related to (i) the collectability of accounts receivable; (ii) write down of excess and obsolete inventories; (iii) intangible assets and goodwill; (iv) the estimated useful lives of long-lived assets; (v) impairment of long-lived assets and financial instruments; (vi) warranty obligations; (vii) the valuation of stock-based compensation awards and financial instruments; (viii) the probability of performance objectives achievement; (ix) the realization of tax assets and estimates of tax liabilities, including reserves for uncertain tax positions; and (x) the recognition and disclosure of contingent liabilities. These estimates and assumptions are based on historical experience and on various other factors which the Company believes to be reasonable under the circumstances. The Company may engage third-party valuation specialists to assist with estimates related to the valuation of financial instruments, assets and stock awards associated with various contractual arrangements. Such estimates often require the selection of appropriate valuation methodologies and significant judgment. Actual results could differ from these estimates under different assumptions or circumstances and such differences could be material. The Company also assessed the impacts of COVID-19 on the above accounting matters as of April 30, 2020 and through the date of this report. While there was not a material impact as of and for the quarter ended April 30, 2020, future actual magnitude and duration of COVID-19, as well as other associated factors, could r esult in material negative impacts to its condensed consolidated financial statements in future reporting periods. |
Concentration of Risk | Concentration of Risk The Company’s products are manufactured, assembled and tested by third-party contractors located primarily in Asia. The Company does not have long-term agreements with these contractors. A significant disruption in the operations of one or more of these contractors would impact the production of the Company’s products which could have a material adverse effect on its business, financial condition and results of operations. A substantial portion of the Company’s revenue is derived from sales through one of its distributors, Wintech Microelectronics Co., Ltd., or Wintech, which serves as its non-exclusive sales representative in Asia other than Japan, and directly to one ODM customer, Chicony Electronics Co., Ltd., or Chicony. Termination of the relationships with these customers could result in a temporary or permanent loss of revenue. Furthermore, any credit issues from these customers could impair their abilities to make timely payment to the Company. See Note 14 for additional information regarding revenue and credit concentration with these customers. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, marketable debt securities and accounts receivable. The Company maintains its cash primarily in checking accounts with reputable financial institutions. Cash deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on deposits of its cash. In order to limit the exposure of each investment, the cash equivalents and marketable debt securities consist primarily of money market funds, asset-backed securities, commercial paper, U.S. government securities and debt securities of corporations which management assesses to be highly liquid. The Company does not hold or issue financial instruments for trading purposes. The Company performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and customers’ credit worthiness. The Company regularly monitors collections and payments from its customers. |
Financial Instruments | Financial Instruments On February 1, 2020, the Company adopted Accounting Standards Update (ASU) No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, using the modified retrospective transition method. Under this new guidance, the Company recognizes credit losses based on a forward-looking current expected credit losses (CECL) model instead of the previous incurred loss model for financial instruments, including accounts receivable. The Company’s accounts receivable are recorded at invoiced amount less an allowance for any potentially uncollectible amounts. Accordingly, the Company makes estimates of expected credit losses for the allowance for doubtful accounts based upon its assessment of various factors, including historical collection experience, the age of the accounts receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The Company considers all highly liquid debt security investments with original maturities of less than three months at the time of purchase to be cash equivalents. Debt security investments that are highly liquid with original maturities at the time of purchase greater than three months are considered marketable debt securities. The Company classifies these investments as “available-for-sale” (AFS) securities. Instead of the previous "other than temporary" impairment model, the Company now estimates the expected losses whenever a security’s fair value is below its amortized cost basis. The expected loss is computed at an individual security level using the discounted cash flow method with the effective interest rate on the purchase date. In the determination of credit-related losses, the Company excludes securities with zero loss expectation such as assets backed by government agencies. There are various factors considered in its assessment of credit-related losses, including the extent to which the fair value is less than the amortized cost basis, adverse conditions related to an industry or an underlying loan obligator, the payment structure of the security, changes to the rating of the security and other factors that may affect the security credit. The credit-related portion of the loss is recognized in other income, net in the condensed consolidated statements of operations but is limited to the difference between the fair value and the amortized cost basis of the security, adjusted for accrued interest. The non-credit-related portion of the loss is recognized in accumulated other comprehensive income in the condensed consolidated balance sheets. The cumulative effect adjustment upon the adoption on February 1, 2020 was immaterial. The credit-related losses and associated allowance amount from the Company’s financial instruments were not material as of April 30, 2020, respectively. |
Restricted Cash | Restricted Cash Amounts included in restricted cash represent those required to be set aside to secure certain transactions in a foreign entity. As of April 30, 2020 and January 31, 2020, the restricted cash was immaterial. The following table presents cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheets, and the sums are presented on the condensed consolidated statements of cash flows: As of April 30, 2020 January 31, 2020 April 30, 2019 January 31, 2019 (in thousands) Cash and cash equivalents $ 236,585 $ 231,403 $ 204,444 $ 194,047 Restricted cash 9 9 11 11 Total as presented in the consolidated statements of cash flows $ 236,594 $ 231,412 $ 204,455 $ 194,058 |
Inventories | Inventories The Company records inventories at the lower of cost or net realizable value. The cost includes materials and other production costs and is computed using standard cost on a first-in, first-out basis. Inventory reserves are recorded for estimated obsolescence or unmarketable inventories based on forecast of future demand and market conditions. Any adjustments to reduce the cost of inventories to their net realizable value are recognized in earnings in the current period. |
Noncancelable Internal-Use Software License | Noncancelable Internal-Use Software License The Company accounts for a noncancelable on premise internal-use software license as the acquisition of an intangible asset and the incurrence of a liability to the extent that all or a portion of the software licensing fees are not paid on or before the license acquisition date. The intangible asset and related liability are recorded at net present value and interest expense is recorded over the payment term. |
Leases | Leases Effective February 1, 2019, the Company adopted Accounting Standards Codification (“ASC”) Topic 842, Leases. As a result, the Company recognizes leases as operating lease right-of-use (“ROU”) assets and corresponding lease liabilities at the lease commencement date based on the present value of future lease payments, while recognizing lease expenses under straight-line method through the lease term. The Company also elected the practical expedient that does not recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases. The Company does not combine lease components with non-lease components, and as a result, the non-lease components are accounted for separately. In determining the present value of lease payments, the Company uses the implicit interest rate if readily determinable. When the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at the lease commencement date. The Company's leases mainly include its worldwide office facilities which are all classified as operating leases. Certain leases include renewal options that are under the Company's discretion. The renewal options are included in the ROU and liability calculation if it is reasonably certain that the Company will exercise the option. The Company's finance leases are immaterial as of April 30, 2020 and January 31, 2020, respectively. |
Revenue Recognition | Revenue Recognition The Company adopted ASC 606, Revenue from Contracts with Customers. As a result, the Company recognizes revenue when control of its goods and services is transferred to its customers. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied. The sale of semiconductor products accounts for the substantial majority of the Company’s consolidated revenue. Sales agreements with customers are renewable periodically and contain terms and conditions with respect to payment, delivery, warranty, supply and other rights. The Company considers an accepted customer purchase order, governed by sales agreement, to be the contract with the customer. For each contract, the Company considers the promise to transfer tangible products to be the identified performance obligation. Product sales contracts may include volume-based tiered pricing or rebates that are fulfilled in cash or product. In determining the transaction price, the Company accounts for the right of returns, cash rebates, commissions and other pricing adjustments as variable consideration , estimates these amounts based on the expected amount to be provided to customers and reduces the revenue recognized. The Company estimates sales returns and rebates based on the Company’s historical patterns of return and pricing credits. As the Company’s standard payment terms are 30 days to 60 days, the contracts have no financing component. Under ASC 606, the Company estimates the total consideration to be received by using the expected value method for each contract, computes weighted average selling price for each unit shipped in cases where there is a material right due to the presence of volume-based tiered pricing, allocates the total consideration between the identified performance obligations, and recognizes revenue when control of its goods and services is transferred to its customers. The Company considers product control to be transferred at a point in time upon shipment or delivery because the Company has a present right to payment at that time, the customer has legal title to the asset, the Company has transferred physical possession of the asset, and the customer has significant risk and rewards of ownership of the asset . The Company also enters into fixed-price engineering service agreements with certain customers. These agreements may include multiple performance obligations, such as software development services, licensing of intellectual property and post-contract customer support, or PCS. These multiple performance obligations are highly interdependent, highly interrelated, are typically not sold separately and do not have standalone selling prices. They are all inputs to generate one combined output which is incorporating the Company’s SoC into the customer’s product. Accordingly, the Company determines that they are not separately identifiable and shall be treated as a single performance obligation. Customers usually pay based on milestones achieved. Because payments received do not correspond directly with the value of the Company’s performance to date, for fixed-price engineering services arrangements, revenue is recognized using the time-based straight line method, which best depicts the Company’s performance toward complete satisfaction of the performance obligation based on the nature of such professional services. Revenues from engineering service agreements were not material for the three months ended April 30, 2020 and 2019, respectively. Timing of revenue recognition may differ from the timing of invoicing to the Company’s customers. The Company records contract assets when revenue is recognized prior to invoicing. The Company’s contract assets are primarily related to satisfied but unbilled performance obligations associated with its engineering service agreements at the reporting date. As of April 30, 2020 and January 31, 2020, the contract assets for these unbilled receivables were not material. The Company’s contract liabilities consist of deferred revenue. The deferred revenue is primarily related to the portion of a transaction price that exceeds the weighted average selling price for products sold to date under tiered-pricing contracts which contain material rights. This deferred revenue is expected to be recognized over the course of the contract when products are delivered for future pricing below the weighted average selling price of the contract. For the three months ended April 30, 2020 and 2019, the Company did not recognize any material revenue adjustment, respectively, related to performance obligations satisfied in prior periods released from this deferred revenue. As of April 30, 2020 and January 31, 2020, the respective deferred revenues were not material. Additionally, the transaction price allocated to unsatisfied, or partially unsatisfied, purchase orders for contracts that are greater than a year was not material as of April 30, 2020 and January 31, 2020, respectively. The Company also elects not to disclose the value of unsatisfied or partially unsatisfied performance obligations due to original expected contract duration of one year or less and elects to exclude amounts collected from customers for all sales taxes from the transaction price |
Cost of Revenue | Cost of Revenue Cost of revenue includes cost of materials, cost associated with packaging and assembly, testing and shipping, cost of personnel, stock-based compensation, logistics and quality assurance, warranty cost, royalty expense, write-downs of inventories and allocation of overhead. |
Research and Development | Research and Development Research and development costs are expensed as incurred and consist primarily of personnel costs, product development costs, which include engineering services, development software and hardware tools, license fees, costs of fabrication of masks for prototype products, other development materials costs, depreciation of equipment and tools and allocation of facility costs, net of any research and development grants. As of April 30, 2020, there was approximately $1.2 million of grants recorded in prepaid expenses and other current assets and approximately $2.8 million of grants recorded in other non-current assets in the condensed consolidated balance sheets. |
Income Taxes | Income Taxes The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. In estimating future tax consequences, generally all expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized. The Company applies authoritative guidance for the accounting for uncertainty in income taxes. The guidance requires that tax effects of a position be recognized only if it is “more likely than not” to be sustained based solely on its technical merits as of the reporting date. Upon estimating its tax positions and tax benefits, the Company considers and evaluates numerous factors, which may require periodic adjustments and which may not reflect the final tax liabilities. The Company adjusts its financial statements to reflect only those tax positions that are more likely than not to be sustained under examination. As part of the process of preparing condensed consolidated financial statements, the Company is required to estimate its taxes in each of the jurisdictions in which it operates. The Company estimates actual current tax exposure together with assessing temporary differences resulting from differing treatment of items, such as accruals and allowances not currently deductible for tax purposes. These differences result in deferred tax assets, which are included in the condensed consolidated balance sheets. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the condensed consolidated statements of operations become deductible expenses under applicable income tax laws, or loss or credit carryforwards are utilized. In assessing whether deferred tax assets may be realized, the Company considers whether it is more likely than not that some portion or all of deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. The Company makes estimates and judgments about its future taxable income based on assumptions that are consistent with its plans and estimates. Should the actual amounts differ from estimates, the amount of valuation allowance could be materially impacted. Any adjustment to the deferred tax asset valuation allowance would be recorded in the condensed consolidated income statement for the periods in which the adjustment is determined to be required. |
Net Income (Loss) Per Ordinary Share | Net Income (Loss) Per Ordinary Share Basic earnings (losses) per share is computed by dividing net income (loss) available to ordinary shareholders by the weighted-average number of ordinary shares outstanding during the period. Diluted earnings (losses) per share is computed by dividing net income (loss) available to ordinary shareholders by the weighted-average number of ordinary shares outstanding during the period increased to include the number of additional ordinary shares that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan, unvested restricted stock and restricted stock units. The dilutive effect of potentially dilutive securities is reflected in diluted earnings (losses) per share by application of the treasury stock method. |
Comprehensive Income (Loss) | Comprehensive Income (Loss) Comprehensive income (loss) includes unrealized gains or losses from available-for-sale securities that are excluded from net income (loss). |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The amendments are effective for public entities in fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The Company did not early adopt and believes the adoption of this new guidance will not have a material impact on its consolidated financial statements and disclosures. There were no other significant updates to the recently issued accounting standards other than as disclosed above. |
Organization and Summary of S_3
Organization and Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Accounting Policies [Abstract] | |
Schedule of Cash, Cash Equivalents and Restricted Cash | The following table presents cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheets, and the sums are presented on the condensed consolidated statements of cash flows: As of April 30, 2020 January 31, 2020 April 30, 2019 January 31, 2019 (in thousands) Cash and cash equivalents $ 236,585 $ 231,403 $ 204,444 $ 194,047 Restricted cash 9 9 11 11 Total as presented in the consolidated statements of cash flows $ 236,594 $ 231,412 $ 204,455 $ 194,058 |
Financial Instruments and Fai_2
Financial Instruments and Fair Value (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Investments All Other Investments [Abstract] | |
Schedule of Available-for-Sale Securities at Fair Value | All of the investments are classified as available-for-sale securities and reported at fair value in the condensed consolidated balance sheets as follows: As of April 30, 2020 Amortized Unrealized Unrealized Losses Fair Value (in thousands) Money market funds $ 2,011 $ — $ — $ 2,011 Commercial paper 61,902 — — 61,902 Corporate bonds 103,681 726 (599 ) 103,808 Asset-backed securities 23,742 152 (18 ) 23,876 U.S. government securities 20,059 144 — 20,203 Total cash equivalents and marketable debt securities $ 211,395 $ 1,022 $ (617 ) $ 211,800 As of January 31, 2020 Amortized Unrealized Gains Unrealized Losses Fair Value (in thousands) Money market funds $ 8,284 $ — $ — $ 8,284 Commercial paper 63,390 — — 63,390 Corporate bonds 95,053 653 — 95,706 Asset-backed securities 23,062 69 (2 ) 23,129 U.S. government securities 20,524 48 — 20,572 Total cash equivalents and marketable debt securities $ 210,313 $ 770 $ (2 ) $ 211,081 |
Schedule Of Unrealized Losses Were In Continuous Position In Less Than Twelve Months | As of April 30, 2020, there were no debt securities with unrealized losses for more than twelve months. As of April 30, 2020 January (in thousands) Included in cash equivalents $ 37,058 $ 37,736 Included in marketable debt securities 174,742 173,345 Total cash equivalents and marketable debt securities $ 211,800 $ 211,081 |
Summary of Contractual Maturities of Investments | The contractual maturities of the investments at April 30, 2020 and January 31, 2020 were as follows: As of April 30, 2020 January (in thousands) Due within one year $ 144,722 $ 146,267 Due within one to three years 67,078 64,814 Total cash equivalents and marketable debt securities $ 211,800 $ 211,081 |
Schedule of Fair Value of Financial Instruments Measured on Recurring Basis | The following tables present the fair value of the financial instruments measured on a recurring basis as of April 30, 2020 and January 31, 2020, respectively: As of April 30, 2020 Total Level 1 Level 2 Level 3 (in thousands) Money market funds $ 2,011 $ 2,011 $ — $ — Commercial paper 61,902 — 61,902 — Corporate bonds 103,808 — 103,808 — Asset-backed securities 23,876 — 23,876 — U.S. government securities 20,203 — 20,203 — Total cash equivalents and marketable debt securities $ 211,800 $ 2,011 $ 209,789 $ — As of January 31, 2020 Total Level 1 Level 2 Level 3 (in thousands) Money market funds $ 8,284 $ 8,284 $ — $ — Commercial paper 63,390 — 63,390 — Corporate bonds 95,706 — 95,706 — Asset-backed securities 23,129 — 23,129 — U.S. government securities 20,572 — 20,572 — Total cash equivalents and marketable debt securities $ 211,081 $ 8,284 $ 202,797 $ — |
Inventories (Tables)
Inventories (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | Inventories at April 30, 2020 and January 31, 2020 consisted of the following: As of April 30, 2020 January (in thousands) Work-in-progress $ 12,773 $ 10,133 Finished goods 9,184 12,838 Total $ 21,957 $ 22,971 |
Property and Equipment, Net (Ta
Property and Equipment, Net (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Property Plant And Equipment [Abstract] | |
Schedule of Property and Equipment | Property and equipment at April 30, 2020 and January 31, 2020 consisted of the following: As of April 30, 2020 January (in thousands) Computer equipment and software $ 10,598 $ 10,282 Machinery and equipment 6,377 6,317 Furniture and fixtures 969 969 Leasehold improvements 2,380 2,356 Construction in progress 70 63 20,394 19,987 Less: accumulated depreciation and amortization (14,993 ) (14,373 ) Total property and equipment, net $ 5,401 $ 5,614 |
Intangible Assets, Net (Tables)
Intangible Assets, Net (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Goodwill And Intangible Assets Disclosure [Abstract] | |
Summary of Carrying Amounts of Intangible Assets | The carrying amounts of intangible assets as of April 30, 2020 and January 31, 2020 were as follows : As of April 30, 2020 As of January 31, 2020 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in thousands) In-process research and development $ 4,100 $ — $ 4,100 $ 4,100 $ — $ 4,100 Internal-use software licenses 27,291 (15,000 ) 12,291 27,203 (13,477 ) 13,726 Total acquired intangible assets $ 31,391 $ (15,000 ) $ 16,391 $ 31,303 $ (13,477 ) $ 17,826 |
Summary of Estimated Future Amortization Expense of Software Licenses | The estimated future amortization expense of these software licenses as of April 30, 2020 is as follows: As of April 30, 2020 Fiscal Year (in thousands) 2021 (9 months remaining) $ 4,319 2022 4,553 2023 3,419 2024 — 2025 — Thereafter — Total future amortization expenses: $ 12,291 |
Accrued and Other Current Lia_2
Accrued and Other Current Liabilities (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Payables And Accruals [Abstract] | |
Schedule of Accrued and Other Current Liabilities | Accrued and other current liabilities at April 30, 2020 and January 31, 2020 consisted of the following: As of April 30, 2020 January (in thousands) Accrued employee compensation $ 9,949 $ 16,874 Accrued rebates 90 54 Accrued product development costs 10,454 10,885 Software license liabilities, current 4,386 4,388 Other accrued liabilities 2,383 2,769 Total accrued and other current liabilities $ 27,262 $ 34,970 |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Leases [Abstract] | |
Schedule of Supplemental Cash Flow Information Related to Leases | Supplemental cash flow information related to leases is as follows: Three Months Ended April 30, 2020 (in thousands) Cash paid for operating leases included in operating cash flows $ 689 Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets $ 88 |
Schedule of Future Minimum Lease Payments for Lease Liabilities | As of April 30, 2020, the weighted average remaining lease term is 4.90 years, and the weighted average discount rate is 4.43 percent. Future minimum lease payments for the lease liabilities are as follows : As of April 30, 2020 Fiscal Year (in thousands) 2021 (9 months remaining) $ 1,784 2022 2,355 2023 1,644 2024 1,693 2025 1,740 Thereafter 1,208 Total future annual minimum lease payments 10,424 Less: interest (937 ) Total lease liabilities $ 9,487 |
Other Long-Term Liabilities (Ta
Other Long-Term Liabilities (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Other Liabilities Disclosure [Abstract] | |
Schedule of Other Long-Term Liabilities | Other long-term liabilities at April 30, 2020 and January 31, 2020 consisted of the following: As of April 30, 2020 January (in thousands) Unrecognized tax benefits, including interest $ 8,782 $ 8,261 Deferred tax liabilities, non-current 1,287 1,288 Software license liabilities, non-current 7,046 8,159 Other long-term liabilities 146 68 Total other long-term liabilities $ 17,261 $ 17,776 |
Capital Stock (Tables)
Capital Stock (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Equity [Abstract] | |
Schedule of Ordinary Shares Reserved for Future Issuance under EIP and ESPP | As of April 30, 2020 and January 31, 2020, the following ordinary shares were reserved for future issuance under the EIP and ESPP: As of April 30, 2020 January 31, 2020 Shares reserved for options, restricted stock and restricted stock units under EIP 7,087,717 6,045,108 Shares reserved for ESPP 2,398,510 2,059,504 |
Stock-based Compensation (Table
Stock-based Compensation (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Classification of Stock-based Compensation | The following table presents the classification of stock-based compensation for the periods indicated: Three Months Ended April 30, 2020 2019 (in thousands) Stock-based compensation: Cost of revenue $ 297 $ 267 Research and development 9,896 10,204 Selling, general and administrative 5,843 5,989 Total stock-based compensation $ 16,036 $ 16,460 |
Weighted-Average Assumptions Used to Estimate Fair Value | The following table sets forth the weighted-average assumptions used to estimate the fair value of stock options and employee stock purchase plan awards for the periods indicated: Three Months Ended April 30, 2020 2019 Stock Options: Volatility 50 % 52 % Risk-free interest rate 0.74 % 2.49 % Expected term (years) 5.89 5.88 Dividend yield 0 % 0 % Employee stock purchase plan awards: Volatility 61 % 48 % Risk-free interest rate 0.29 % 2.52 % Expected term (years) 0.5 0.5 Dividend yield 0 % 0 % |
Stock Option Activities | The following table summarizes stock option activities for the period indicated: Option Outstanding Weighted- Total Average Weighted- Value Of Remaining Aggregate Weighted- Average Options Contractual Intrinsic Average Grant-date Exercised Term Value Shares Exercise Fair Value (in (in years) (in Outstanding at January 31, 2020 1,124,646 $ 32.93 Granted 7,200 50.77 $ 23.85 Exercised (75,870 ) 14.66 $ 3,369 Forfeited (2,929 ) 47.68 Expired (350 ) 40.60 Outstanding at April 30, 2020 1,052,697 34.33 4.28 $ 22,404 Exercisable at April 30, 2020 903,782 $ 31.92 3.59 $ 21,555 |
Restricted Stock Units Activities | The following table summarizes the restricted stock units activities for the period indicated: Weighted- Average Grant-Date Shares Fair Value Unvested at January 31, 2020 2,617,266 $ 50.30 Granted 505,261 53.26 Vested (402,773 ) 51.89 Forfeited (36,338 ) 54.75 Unvested at April 30, 2020 2,683,416 $ 50.56 |
Net Loss Per Ordinary Share (Ta
Net Loss Per Ordinary Share (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Earnings Per Share [Abstract] | |
Computation of Basic and Diluted Loss Per Ordinary Share | The following table sets forth the computation of basic and diluted loss per ordinary share for the periods indicated: Three 2020 2019 (in thousands, except share and per share data) Numerator: Net loss $ (15,463 ) $ (17,311 ) Denominator: Weighted-average ordinary shares - basic 34,080,330 32,492,044 Weighted-average ordinary shares - diluted 34,080,330 32,492,044 Net loss per ordinary share: Basic $ (0.45 ) $ (0.53 ) Diluted $ (0.45 ) $ (0.53 ) |
Weighted-Average Potentially Dilutive Securities Excluded from Computation of Diluted Loss Per Ordinary Share | The following weighted-average potentially dilutive securities were excluded from the computation of diluted loss per ordinary share as their effect would have been antidilutive: Three Months Ended April 30, 2020 2019 Options to purchase ordinary shares 771,769 1,003,060 Restricted stock and restricted stock units 1,441,462 926,156 Employee stock purchase plan 31,092 17,469 2,244,323 1,946,685 |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
Summary of Income Taxes | The following table provides details of income taxes for the periods indicated: Three Months Ended April 30, 2020 2019 (in thousands) Loss before income taxes $ (14,337 ) $ (16,045 ) Provision for income taxes 1,126 1,266 Effective tax rate (7.9)% (7.9)% |
Segment Reporting (Tables)
Segment Reporting (Tables) | 3 Months Ended |
Apr. 30, 2020 | |
Segment Reporting [Abstract] | |
Company's Revenue by Geographic Region Based on Bill-to Location | The following table sets forth the Company’s revenue by geographic region based on bill-to location for the periods indicated: Three Months Ended April 30, 2020 2019 (in thousands) Taiwan $ 34,460 $ 27,600 Asia Pacific 14,028 14,488 Europe 2,253 3,483 North America other than United States 2,673 883 United States 1,231 734 Total revenue $ 54,645 $ 47,188 |
Organization and Summary of S_4
Organization and Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents and Restricted Cash (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 | Apr. 30, 2019 | Jan. 31, 2019 |
Cash And Cash Equivalents [Abstract] | ||||
Cash and cash equivalents | $ 236,585 | $ 231,403 | $ 204,444 | $ 194,047 |
Restricted cash | 9 | 9 | 11 | 11 |
Total as presented in the consolidated statements of cash flows | $ 236,594 | $ 231,412 | $ 204,455 | $ 194,058 |
Organization and Summary of S_5
Organization and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Summary Of Significant Accounting Policies [Line Items] | ||
Material inventory losses recognized | $ 0 | $ 0 |
Prepaid Expenses and Other Current Assets [Member] | ||
Summary Of Significant Accounting Policies [Line Items] | ||
Grants recorded | 1,200,000 | |
Other Non-current Assets [Member] | ||
Summary Of Significant Accounting Policies [Line Items] | ||
Grants recorded | $ 2,800,000 |
Financial Instruments and Fai_3
Financial Instruments and Fair Value - Schedule of Available-for-Sale Securities at Fair Value (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | $ 211,395 | $ 210,313 |
Unrealized Gains | 1,022 | 770 |
Unrealized Losses | (617) | (2) |
Fair Value | 211,800 | 211,081 |
Money market funds [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 2,011 | 8,284 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Fair Value | 2,011 | 8,284 |
Commercial paper [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 61,902 | 63,390 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Fair Value | 61,902 | 63,390 |
Corporate bonds [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 103,681 | 95,053 |
Unrealized Gains | 726 | 653 |
Unrealized Losses | (599) | |
Fair Value | 103,808 | 95,706 |
Asset-backed securities [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 23,742 | 23,062 |
Unrealized Gains | 152 | 69 |
Unrealized Losses | (18) | (2) |
Fair Value | 23,876 | 23,129 |
U.S. government securities [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 20,059 | 20,524 |
Unrealized Gains | 144 | 48 |
Fair Value | $ 20,203 | $ 20,572 |
Financial Instruments and Fai_4
Financial Instruments and Fair Value - Additional Information (Detail) | Apr. 30, 2020Security |
Investments Debt And Equity Securities [Abstract] | |
Number of debt securities with unrealized losses for more than twelve months | 0 |
Financial Instruments And Fai_5
Financial Instruments And Fair Value - Schedule Of Unrealized Losses Were In Continuous Position In Less Than Twelve Months (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Schedule of Available-for-sale Securities [Line Items] | ||
Total cash equivalents and marketable debt securities | $ 211,800 | $ 211,081 |
Included in cash equivalents [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Total cash equivalents and marketable debt securities | 37,058 | 37,736 |
Included in marketable debt securities [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Total cash equivalents and marketable debt securities | $ 174,742 | $ 173,345 |
Financial Instruments and Fai_6
Financial Instruments and Fair Value - Summary of Contractual Maturities of Investments (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Available For Sale Securities Debt Maturities Fair Value [Abstract] | ||
Due within one year | $ 144,722 | $ 146,267 |
Due within one to three years | 67,078 | 64,814 |
Total cash equivalents and marketable debt securities | $ 211,800 | $ 211,081 |
Financial Instruments and Fai_7
Financial Instruments and Fair Value - Schedule of Fair Value of Financial Instruments Measured on Recurring Basis (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | $ 211,800 | $ 211,081 |
Money market funds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 2,011 | 8,284 |
Commercial paper [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 61,902 | 63,390 |
Corporate bonds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 103,808 | 95,706 |
Asset-backed securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 23,876 | 23,129 |
U.S. government securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 20,203 | 20,572 |
Level 1 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 2,011 | 8,284 |
Level 1 [Member] | Money market funds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 2,011 | 8,284 |
Level 1 [Member] | Commercial paper [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 1 [Member] | Corporate bonds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 1 [Member] | Asset-backed securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 1 [Member] | U.S. government securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 2 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 209,789 | 202,797 |
Level 2 [Member] | Money market funds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 2 [Member] | Commercial paper [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 61,902 | 63,390 |
Level 2 [Member] | Corporate bonds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 103,808 | 95,706 |
Level 2 [Member] | Asset-backed securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 23,876 | 23,129 |
Level 2 [Member] | U.S. government securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 20,203 | 20,572 |
Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 3 [Member] | Money market funds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 3 [Member] | Commercial paper [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 3 [Member] | Corporate bonds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 3 [Member] | Asset-backed securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | 0 | 0 |
Level 3 [Member] | U.S. government securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash equivalents and marketable debt securities | $ 0 | $ 0 |
Inventories - Schedule of Inven
Inventories - Schedule of Inventory (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Inventory Disclosure [Abstract] | ||
Work-in-progress | $ 12,773 | $ 10,133 |
Finished goods | 9,184 | 12,838 |
Total | $ 21,957 | $ 22,971 |
Property and Equipment, Net - A
Property and Equipment, Net - Additional Information (Detail) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Property Plant And Equipment [Abstract] | ||
Depreciation of property and equipment | $ 0.7 | $ 0.7 |
Property and Equipment, Net - S
Property and Equipment, Net - Schedule of Property and Equipment (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 | Jan. 31, 2019 |
Property Plant And Equipment [Line Items] | |||
Property and equipment, gross | $ 20,394 | $ 19,987 | |
Less: accumulated depreciation and amortization | (14,993) | (14,373) | |
Total property and equipment, net | 5,401 | $ 5,614 | 5,614 |
Computer equipment and software [Member] | |||
Property Plant And Equipment [Line Items] | |||
Property and equipment, gross | 10,598 | 10,282 | |
Machinery and equipment [Member] | |||
Property Plant And Equipment [Line Items] | |||
Property and equipment, gross | 6,377 | 6,317 | |
Furniture and fixtures [Member] | |||
Property Plant And Equipment [Line Items] | |||
Property and equipment, gross | 969 | 969 | |
Leasehold improvements [Member] | |||
Property Plant And Equipment [Line Items] | |||
Property and equipment, gross | 2,380 | 2,356 | |
Construction in progress [Member] | |||
Property Plant And Equipment [Line Items] | |||
Property and equipment, gross | $ 70 | $ 63 |
Intangible Assets, Net - Additi
Intangible Assets, Net - Additional Information (Detail) - USD ($) | 3 Months Ended | |||
Apr. 30, 2020 | Apr. 30, 2019 | Jan. 31, 2020 | Jun. 25, 2015 | |
Finite Lived Intangible Assets [Line Items] | ||||
Intangible assets, net of amortization expense | $ 16,391,000 | $ 17,826,000 | ||
Accumulated amortization of intangible asset | 15,000,000 | 13,477,000 | ||
Liabilities associated with noncancelable internal-use software license at net present value, current | 4,386,000 | 4,388,000 | ||
Liabilities associated with noncancelable internal-use software license at net present value, non-current | 7,046,000 | 8,159,000 | ||
Impairment of intangible assets | 0 | $ 0 | ||
IPR&D [Member] | ||||
Finite Lived Intangible Assets [Line Items] | ||||
Intangible assets, net of amortization expense | 4,100,000 | 4,100,000 | ||
Accumulated amortization of intangible asset | 0 | 0 | ||
IPR&D [Member] | Vis Lab SRL [Member] | ||||
Finite Lived Intangible Assets [Line Items] | ||||
Intangible assets acquired | $ 4,100,000 | |||
Internal-use software licenses [Member] | ||||
Finite Lived Intangible Assets [Line Items] | ||||
Intangible assets, net of amortization expense | 12,291,000 | 13,726,000 | ||
Accumulated amortization of intangible asset | 15,000,000 | $ 13,477,000 | ||
Amortization expense | $ 1,500,000 | $ 1,300,000 |
Intangible Assets, Net - Summar
Intangible Assets, Net - Summary of Carrying Amounts of Intangible Assets (Detail) - USD ($) | Apr. 30, 2020 | Jan. 31, 2020 |
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 31,391,000 | $ 31,303,000 |
Accumulated Amortization | (15,000,000) | (13,477,000) |
Net Carrying Amount | 16,391,000 | 17,826,000 |
In-process research and development [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 4,100,000 | 4,100,000 |
Accumulated Amortization | 0 | 0 |
Net Carrying Amount | 4,100,000 | 4,100,000 |
Internal-use software licenses [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 27,291,000 | 27,203,000 |
Accumulated Amortization | (15,000,000) | (13,477,000) |
Net Carrying Amount | $ 12,291,000 | $ 13,726,000 |
Intangible Assets, Net - Summ_2
Intangible Assets, Net - Summary of Estimated Future Amortization Expense of Software Licenses (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Finite Lived Intangible Assets [Line Items] | ||
Net Carrying Amount | $ 16,391 | $ 17,826 |
Internal-use software licenses [Member] | ||
Finite Lived Intangible Assets [Line Items] | ||
2021 (9 months remaining) | 4,319 | |
2022 | 4,553 | |
2023 | 3,419 | |
2024 | 0 | |
2025 | 0 | |
Thereafter | 0 | |
Net Carrying Amount | $ 12,291 | $ 13,726 |
Accrued and Other Current Lia_3
Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Payables And Accruals [Abstract] | ||
Accrued employee compensation | $ 9,949 | $ 16,874 |
Accrued rebates | 90 | 54 |
Accrued product development costs | 10,454 | 10,885 |
Software license liabilities, current | 4,386 | 4,388 |
Other accrued liabilities | 2,383 | 2,769 |
Total accrued and other current liabilities | $ 27,262 | $ 34,970 |
Accrued and Other Current Lia_4
Accrued and Other Current Liabilities - Additional Information (Detail) $ in Millions | 1 Months Ended |
Mar. 31, 2020USD ($) | |
Schedule of Accrued Liabilities [Line Items] | |
Annual bonus paid | $ 7.7 |
Cash [Member] | |
Schedule of Accrued Liabilities [Line Items] | |
Annual bonus paid | 2.3 |
Restricted stock units [Member] | |
Schedule of Accrued Liabilities [Line Items] | |
Annual bonus paid | $ 5.4 |
Leases - Additional Information
Leases - Additional Information (Detail) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Leases [Abstract] | ||
Operating lease expense | $ 0.7 | $ 0.7 |
Weighted-average remaining lease term - operating leases | 4 years 10 months 24 days | |
Weighted-average discount rate - operating leases | 4.43% |
Leases - Schedule of Supplement
Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Detail) $ in Thousands | 3 Months Ended |
Apr. 30, 2020USD ($) | |
Leases [Abstract] | |
Cash paid for operating leases included in operating cash flows | $ 689 |
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets | $ 88 |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Lease Payments for Lease Liabilities (Detail) $ in Thousands | Apr. 30, 2020USD ($) |
Leases [Abstract] | |
2021 (9 months remaining) | $ 1,784 |
2022 | 2,355 |
2023 | 1,644 |
2024 | 1,693 |
2025 | 1,740 |
Thereafter | 1,208 |
Total future annual minimum lease payments | 10,424 |
Less: interest | (937) |
Total lease liabilities | $ 9,487 |
Other Long-Term Liabilities - S
Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Other Liabilities Disclosure [Abstract] | ||
Unrecognized tax benefits, including interest | $ 8,782 | $ 8,261 |
Deferred tax liabilities, non-current | 1,287 | 1,288 |
Software license liabilities, non-current | 7,046 | 8,159 |
Other long-term liabilities | 146 | 68 |
Total other long-term liabilities | $ 17,261 | $ 17,776 |
Capital Stock - Additional Info
Capital Stock - Additional Information (Detail) - USD ($) | Mar. 16, 2020 | Feb. 01, 2020 | Jun. 30, 2016 | Apr. 30, 2020 | Apr. 30, 2020 | Jan. 31, 2020 |
Class Of Stock [Line Items] | ||||||
Preference shares, shares authorized | 20,000,000 | 20,000,000 | 20,000,000 | |||
Preference shares, par value | $ 0.00045 | $ 0.00045 | $ 0.00045 | |||
Preference shares, shares issued | 0 | 0 | 0 | |||
Preference shares, shares outstanding | 0 | 0 | 0 | |||
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 | 200,000,000 | |||
Stock repurchased, shares | 25,719 | 4,011,595 | ||||
Stock repurchased during period, cash | $ 1,000,000 | $ 1,000,000 | $ 175,800,000 | |||
Stock repurchase program, inception period | 2016-06 | |||||
Amount authorized under stock repurchase program | 275,000,000 | 275,000,000 | ||||
Amount available under stock repurchase program | $ 49,000,000 | $ 49,000,000 | ||||
2012 Equity Incentive Plan [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Additional ordinary shares reserved for issuance | 1,521,252 | |||||
2012 Equity Incentive Plan [Member] | Scenario, plan automatically increased by the lessor of [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Annual increase in ordinary shares for available for future issuance | 3,500,000 | |||||
Annual shares increase for future issuance by percentage under 2012 equity incentive plan | 4.50% | |||||
Amended and Restated 2012 Employee Stock Purchase Plan [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Additional ordinary shares reserved for issuance | 422,570 | |||||
Amended and Restated 2012 Employee Stock Purchase Plan [Member] | Scenario, plan automatically increased by the lessor of [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Annual increase in ordinary shares for available for future issuance | 1,500,000 | |||||
Annual shares increase for future issuance by percentage under 2012 employee stock purchase plan | 1.25% |
Capital Stock - Schedule of Ord
Capital Stock - Schedule of Ordinary Shares Reserved for Future Issuance under EIP and ESPP (Detail) - shares | Apr. 30, 2020 | Jan. 31, 2020 |
EIP [Member] | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Shares reserved | 7,087,717 | 6,045,108 |
ESPP [Member] | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Shares reserved | 2,398,510 | 2,059,504 |
Stock-based Compensation - Clas
Stock-based Compensation - Classification of Stock-based Compensation (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Stock-based compensation: | ||
Total stock-based compensation | $ 16,036 | $ 16,460 |
Cost of revenue [Member] | ||
Stock-based compensation: | ||
Total stock-based compensation | 297 | 267 |
Research and development [Member] | ||
Stock-based compensation: | ||
Total stock-based compensation | 9,896 | 10,204 |
Selling, general and administrative [Member] | ||
Stock-based compensation: | ||
Total stock-based compensation | $ 5,843 | $ 5,989 |
Stock-based Compensation - Addi
Stock-based Compensation - Additional Information (Detail) $ / shares in Units, $ in Millions | 3 Months Ended |
Apr. 30, 2020USD ($)$ / shares | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Accrued share based compensation expense | $ 0.8 |
Closing price of ordinary shares | $ / shares | $ 52.58 |
Stock options [Member] | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Total unrecognized compensation cost, stock options | $ 3.5 |
Weighted average recognition period | 2 years 4 months 20 days |
Restricted stock units [Member] | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Total unrecognized compensation cost, restricted stock units | $ 122.8 |
Weighted average recognition period | 2 years 5 months 1 day |
Aggregate intrinsic value of unvested restricted stock units | $ 141.1 |
Stock-based Compensation - Weig
Stock-based Compensation - Weighted-Average Assumptions Used to Estimate Fair Value (Detail) | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Stock options [Member] | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Volatility | 50.00% | 52.00% |
Risk-free interest rate | 0.74% | 2.49% |
Expected term (years) | 5 years 10 months 20 days | 5 years 10 months 17 days |
Dividend yield | 0.00% | 0.00% |
Employee stock purchase plan awards [Member] | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Volatility | 61.00% | 48.00% |
Risk-free interest rate | 0.29% | 2.52% |
Expected term (years) | 6 months | 6 months |
Dividend yield | 0.00% | 0.00% |
Stock-based Compensation - Stoc
Stock-based Compensation - Stock Option Activities (Detail) $ / shares in Units, $ in Thousands | 3 Months Ended |
Apr. 30, 2020USD ($)$ / sharesshares | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Shares, Outstanding | shares | 1,124,646 |
Shares, Granted | shares | 7,200 |
Shares, Exercised | shares | (75,870) |
Shares, Forfeited | shares | (2,929) |
Shares, Expired | shares | (350) |
Shares, Outstanding | shares | 1,052,697 |
Shares, Exercisable | shares | 903,782 |
Weighted-Average Exercise Price, Outstanding | $ 32.93 |
Weighted-Average Exercise Price, Granted | 50.77 |
Weighted-Average Exercise Price, Exercised | 14.66 |
Weighted-Average Exercise Price, Forfeited | 47.68 |
Weighted-Average Exercise Price, Expired | 40.60 |
Weighted-Average Exercise Price, Outstanding | 34.33 |
Weighted-Average Exercise Price, Exercisable | 31.92 |
Weighted-Average Grant-date Fair Value, Granted | $ 23.85 |
Total Intrinsic Value Of Options Exercised | $ | $ 3,369 |
Weighted-Average Remaining Contractual Term, Outstanding | 4 years 3 months 10 days |
Weighted-Average Remaining Contractual Term, Exercisable | 3 years 7 months 2 days |
Aggregate Intrinsic Value, Outstanding | $ | $ 22,404 |
Aggregate Intrinsic Value, Exercisable | $ | $ 21,555 |
Stock-based Compensation - Rest
Stock-based Compensation - Restricted Stock Units Activities (Detail) - Restricted Stock Units [Member] | 3 Months Ended |
Apr. 30, 2020$ / sharesshares | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Shares, Unvested, beginning balance | shares | 2,617,266 |
Shares, Granted | shares | 505,261 |
Shares, Vested | shares | (402,773) |
Shares, Forfeited | shares | (36,338) |
Shares, Unvested, ending balance | shares | 2,683,416 |
Weighted-Average Grant-Date Fair Value, Unvested, beginning balance | $ / shares | $ 50.30 |
Weighted-Average Grant-Date Fair Value, Granted | $ / shares | 53.26 |
Weighted-Average Grant-Date Fair Value, Vested | $ / shares | 51.89 |
Weighted-Average Grant-Date Fair Value, Forfeited | $ / shares | 54.75 |
Weighted-Average Grant-Date Fair Value, Unvested, ending balance | $ / shares | $ 50.56 |
Net Loss Per Ordinary Share - C
Net Loss Per Ordinary Share - Computation of Basic and Diluted Loss Per Ordinary Share (Detail) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Numerator: | ||
Net loss | $ (15,463) | $ (17,311) |
Denominator: | ||
Weighted-average ordinary shares - basic | 34,080,330 | 32,492,044 |
Weighted-average ordinary shares - diluted | 34,080,330 | 32,492,044 |
Net loss per ordinary share: | ||
Basic | $ (0.45) | $ (0.53) |
Diluted | $ (0.45) | $ (0.53) |
Net Loss Per Ordinary Share - W
Net Loss Per Ordinary Share - Weighted-Average Potentially Dilutive Securities Excluded from Computation of Diluted Loss Per Ordinary Share (Detail) - shares | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive shares excluded from computation of earnings per share | 2,244,323 | 1,946,685 |
Options to purchase ordinary shares [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive shares excluded from computation of earnings per share | 771,769 | 1,003,060 |
Restricted stock and restricted stock units [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive shares excluded from computation of earnings per share | 1,441,462 | 926,156 |
Employee stock purchase plan awards [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive shares excluded from computation of earnings per share | 31,092 | 17,469 |
Income Taxes - Summary of Incom
Income Taxes - Summary of Income Taxes (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Income Tax Disclosure [Abstract] | ||
Loss before income taxes | $ (14,337) | $ (16,045) |
Provision for income taxes | $ 1,126 | $ 1,266 |
Effective tax rate | (7.90%) | (7.90%) |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Income Taxes [Line Items] | ||
Provision for income taxes | $ 1,126 | $ 1,266 |
Unrecognized tax benefits | $ 43,300 | |
U.S. federal tax authorities [Member] | Earliest tax year [Member] | ||
Income Taxes [Line Items] | ||
Income tax examination, year | 2013 | |
U.S. federal tax authorities [Member] | Latest tax year [Member] | ||
Income Taxes [Line Items] | ||
Income tax examination, year | 2019 | |
U.S. state tax authorities [Member] | Earliest tax year [Member] | ||
Income Taxes [Line Items] | ||
Income tax examination, year | 2009 | |
U.S. state tax authorities [Member] | Latest tax year [Member] | ||
Income Taxes [Line Items] | ||
Income tax examination, year | 2019 | |
Foreign tax authorities [Member] | Earliest tax year [Member] | ||
Income Taxes [Line Items] | ||
Income tax examination, year | 2014 | |
Foreign tax authorities [Member] | Latest tax year [Member] | ||
Income Taxes [Line Items] | ||
Income tax examination, year | 2019 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) | 3 Months Ended | 12 Months Ended |
Apr. 30, 2020 | Jan. 31, 2020 | |
Loss Contingencies [Line Items] | ||
Total manufacturing purchase commitments | $ 32,600,000 | $ 35,900,000 |
Indemnification agreement [Member] | ||
Loss Contingencies [Line Items] | ||
Payments under indemnification obligations | 0 | 0 |
Liabilities recorded under indemnification obligations | $ 0 | $ 0 |
Segment Reporting - Additional
Segment Reporting - Additional Information (Detail) $ in Thousands | 3 Months Ended | |||
Apr. 30, 2020USD ($)Segment | Apr. 30, 2019 | Jan. 31, 2020USD ($) | Jan. 31, 2019USD ($) | |
Concentration Risk [Line Items] | ||||
Number of reportable segment | Segment | 1 | |||
Property and equipment, net | $ 5,401 | $ 5,614 | $ 5,614 | |
Accounts receivable | 20,684 | $ 18,487 | ||
Wintech [Member] | Credit concentration risk [Member] | ||||
Concentration Risk [Line Items] | ||||
Accounts receivable | 6,300 | |||
Chicony [Member] | Credit concentration risk [Member] | ||||
Concentration Risk [Line Items] | ||||
Accounts receivable | $ 8,700 | |||
Sales revenue, net [Member] | Wintech [Member] | Customer concentration risk [Member] | ||||
Concentration Risk [Line Items] | ||||
Percentage of revenue | 63.00% | 59.00% | ||
Sales revenue, net [Member] | Chicony [Member] | Customer concentration risk [Member] | ||||
Concentration Risk [Line Items] | ||||
Percentage of revenue | 15.00% | 18.00% | ||
United States [Member] | ||||
Concentration Risk [Line Items] | ||||
Property and equipment, net | $ 1,700 | |||
Asia Pacific [Member] | ||||
Concentration Risk [Line Items] | ||||
Property and equipment, net | 2,600 | |||
Europe [Member] | ||||
Concentration Risk [Line Items] | ||||
Property and equipment, net | $ 1,000 |
Segment Reporting - Company's R
Segment Reporting - Company's Revenue by Geographic Region Based on Bill-to Location (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 30, 2020 | Apr. 30, 2019 | |
Revenue from External Customer [Line Items] | ||
Total revenue | $ 54,645 | $ 47,188 |
Taiwan [Member] | ||
Revenue from External Customer [Line Items] | ||
Total revenue | 34,460 | 27,600 |
Asia Pacific [Member] | ||
Revenue from External Customer [Line Items] | ||
Total revenue | 14,028 | 14,488 |
Europe [Member] | ||
Revenue from External Customer [Line Items] | ||
Total revenue | 2,253 | 3,483 |
North America other than United States [Member] | ||
Revenue from External Customer [Line Items] | ||
Total revenue | 2,673 | 883 |
United States [Member] | ||
Revenue from External Customer [Line Items] | ||
Total revenue | $ 1,231 | $ 734 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Detail) - USD ($) | Jun. 05, 2020 | May 29, 2020 | Mar. 16, 2020 | May 29, 2019 | Apr. 30, 2020 |
Subsequent Event [Line Items] | |||||
Amount authorized under stock repurchase program | $ 275,000,000 | ||||
Stock repurchased, shares | 25,719 | 4,011,595 | |||
Amount available under stock repurchase program | $ 49,000,000 | ||||
Stock Repurchase Program $50.0 Million Authorization [Member] | |||||
Subsequent Event [Line Items] | |||||
Stock repurchase program, authorization date | May 29, 2019 | ||||
Stock repurchase program, expiration date | Jun. 30, 2020 | ||||
Stock Repurchase Program $50.0 Million Authorization [Member] | Maximum [Member] | |||||
Subsequent Event [Line Items] | |||||
Amount authorized under stock repurchase program | $ 50,000,000 | ||||
Subsequent Event [Member] | |||||
Subsequent Event [Line Items] | |||||
Stock repurchase program, extended expiration period | 12 months | ||||
Stock repurchase program, extended expiration date | Jun. 30, 2021 | ||||
Stock repurchased, shares | 25,719 | ||||
Amount available under stock repurchase program | $ 49,000,000 |